Skip to main content
Caplight Logo









Evecxia Therapeutics

Evecxia Therapeutics

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://evecxia.com/

Last Round

VC Round

Sep 22, 2025

Total Funding Raised

$6.5M

Company Overview

Evecxia Therapeutics is a biotechnology company that develops proprietary drug delivery technologies to amplify serotonin synthesis for the treatment of neuropsychiatric disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Mental Health

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaltreatment-resistant depressionserotonin modulationclinical-stage biotechadjunctive therapysleep disorders5-hydroxytryptophan5-HTPdrug developmentneuropsychiatrymental health therapeuticsclinical trialsCNS drug discoverypharma pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evecxia Therapeutics Comparables

Compare Evecxia Therapeutics with similar companies based on industry and business-model similarity.

Evecxia Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Clexio Biosciences
80%
Autobahn Therapeutics
77%
EmbarkNeuro
74%

Evecxia Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 22, 2025
VC RoundAug 27, 2021
Series AJun 30, 2020

Key People

Founding team and executive leadership

Jacob Pade Ramsøe Jacobsen

Chief Executive Officer

Executive Team

Evecxia Therapeutics Investors

Notable investors and investment history

Evecxia Therapeutics investors
InvestorRounds
Collage Venture PartnersVC Round
Transhuman CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors grew 103% MoM.

  • May 2, 2025

    Monthly visitors increased 33% MoM.

Evecxia Therapeutics Filings

Explore SEC and related filing metadata, where available.

Evecxia Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Evecxia Therapeutics's valuation, stock price, and market status.

Is Evecxia Therapeutics a public or private company?

Evecxia Therapeutics is a private company.

What is the current stock price of Evecxia Therapeutics?

Evecxia Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Evecxia Therapeutics worth (valuation)?

Valuation information for Evecxia Therapeutics is not publicly available.

Can I buy Evecxia Therapeutics stock?

Evecxia Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Evecxia Therapeutics's last funding round?

Evecxia Therapeutics's most recent funding round was VC Round on September 22, 2025.

Who are the main investors in Evecxia Therapeutics?

Key investors in Evecxia Therapeutics include Collage Venture Partners.

Will Evecxia Therapeutics IPO soon?

No public IPO plans have been announced for Evecxia Therapeutics.

How can I track Evecxia Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Evecxia Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range6
Year Founded2013
Last FundingSep 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?